EGFR and pancreatic neoplasm: EGFR and its ligands, epidermal growth factor (EGF) and tumor growth factor-α (TGF-α), are coexpressed in the cells, which may contribute to the aggressiveness of pancreatic cancer by continuous EGFR signaling [8,9].